• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆碱能性荨麻疹:不止是一种简单的诱发性荨麻疹。

Cholinergic urticaria: More than a simple inducible urticaria.

作者信息

Kim Hee Joo, Lee Min-Geol

机构信息

Department of Dermatology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Australas J Dermatol. 2017 Nov;58(4):e193-e198. doi: 10.1111/ajd.12496. Epub 2016 May 13.

DOI:10.1111/ajd.12496
PMID:27173142
Abstract

BACKGROUND

Cholinergic urticaria (ChU) is characterized by small wheals induced by an elevated core temperature. Its pathomechanism and various aspects of its clinical manifestations are still poorly understood. This study aimed to evaluate the spectrum of symptoms and signs of ChU in Korean patients.

METHODS

We retrospectively reviewed the medical records of patients diagnosed with ChU.

RESULTS

Among 203 patients (188 male and 15 female), 29 (14%) complained only of an itching or burning sensation without visible skin eruption. The prevalence of ChU was highest in patients in their twenties (56%), while most patients first developed their symptoms during their teens (65%). Patients with a visible skin eruption showed better responses to antihistamines than those without skin lesions.

CONCLUSIONS

Physicians should consider the varying manifestations of ChU, including cholinergic pruritus and erythema as minor variants, to provide better management of ChU.

摘要

背景

胆碱能性荨麻疹(ChU)的特征是核心体温升高诱发小风团。其发病机制及临床表现的各个方面仍知之甚少。本研究旨在评估韩国患者中ChU的症状和体征范围。

方法

我们回顾性分析了诊断为ChU的患者的病历。

结果

在203例患者(188例男性和15例女性)中,29例(14%)仅主诉有瘙痒或烧灼感,无可见皮疹。ChU在二十多岁的患者中患病率最高(56%),而大多数患者在十几岁时首次出现症状(65%)。有可见皮疹的患者对抗组胺药的反应比无皮肤损害的患者更好。

结论

医生应考虑ChU的不同表现,包括将胆碱能性瘙痒和红斑视为轻微变异型,以便更好地管理ChU。

相似文献

1
Cholinergic urticaria: More than a simple inducible urticaria.胆碱能性荨麻疹:不止是一种简单的诱发性荨麻疹。
Australas J Dermatol. 2017 Nov;58(4):e193-e198. doi: 10.1111/ajd.12496. Epub 2016 May 13.
2
A case of severe refractory chronic urticaria: a novel method for evaluation and treatment.一例严重难治性慢性荨麻疹:一种评估与治疗的新方法。
Allergy Asthma Proc. 2009 May-Jun;30(3):333-7. doi: 10.2500/aap.2009.30.3237.
3
The significance of hypersensitivity to autologous sweat and serum in cholinergic urticaria: cholinergic urticaria may have different subtypes.胆碱能性荨麻疹中对自体汗液和血清过敏的意义:胆碱能性荨麻疹可能有不同亚型。
Int J Dermatol. 2015 Jul;54(7):771-7. doi: 10.1111/ijd.12549. Epub 2014 Jul 29.
4
Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis.汗液抗原可诱导伴有特应性素质的胆碱能性荨麻疹患者嗜碱性粒细胞释放组胺。
Br J Dermatol. 2009 Feb;160(2):426-8. doi: 10.1111/j.1365-2133.2008.08862.x. Epub 2008 Sep 20.
5
Cold, red, itching, and miserable.冰冷、发红、瘙痒,难受至极。
Mil Med. 2013 Sep;178(9):e1043-4. doi: 10.7205/MILMED-D-13-00120.
6
[A child with substantially itchy bumps on the back].[一名背部有大量瘙痒性皮疹的儿童]。
Ned Tijdschr Geneeskd. 2015;159:A9512.
7
Solar urticaria - An Australian case series of 83 patients.日光性荨麻疹——83 例澳大利亚患者的病例系列。
Australas J Dermatol. 2019 May;60(2):110-117. doi: 10.1111/ajd.12975. Epub 2018 Dec 25.
8
Diagnosis and management of cold urticaria.寒冷性荨麻疹的诊断与管理
Cutis. 2016 Jan;97(1):59-62.
9
Itch in Urticaria Management.荨麻疹治疗中的瘙痒
Curr Probl Dermatol. 2016;50:77-85. doi: 10.1159/000446047. Epub 2016 Aug 23.
10
Cold-induced cholinergic urticaria--case report.寒冷性胆碱能性荨麻疹——病例报告
Ann Allergy. 1989 Jul;63(1):29-30.

引用本文的文献

1
Omalizumab for cholinergic pruritus in a renal transplant and hemodialysis patient.奥马珠单抗治疗肾移植和血液透析患者的胆碱能性瘙痒症
An Bras Dermatol. 2025 Aug 1;100(5):501167. doi: 10.1016/j.abd.2025.501167.
2
Altered Sweat Composition Due to Changes in Tight Junction Expression of Sweat Glands in Cholinergic Urticaria Patients.胆碱能性荨麻疹患者因汗腺紧密连接表达改变而导致汗液成分改变。
Int J Mol Sci. 2024 Apr 25;25(9):4658. doi: 10.3390/ijms25094658.
3
A single-blind, randomized, crossover study on the efficacy of icatibant for sweating-induced dermal pain (icatibant for sweating-induced dermal pain).
一项关于依卡替班治疗出汗引起的皮肤疼痛的疗效的单盲、随机、交叉研究(依卡替班治疗出汗引起的皮肤疼痛)。
Medicine (Baltimore). 2023 Jun 9;102(23):e33971. doi: 10.1097/MD.0000000000033971.
4
Management of chronic urticaria in children: a clinical guideline.儿童慢性荨麻疹的管理:临床指南。
Ital J Pediatr. 2019 Aug 15;45(1):101. doi: 10.1186/s13052-019-0695-x.